Coherus Oncology (CHRS) EBIT (2013 - 2026)
Coherus Oncology's EBIT was -$32.33 million in Q2 2026, compared with -$45.49 million a year earlier.
Analysis
Coherus Oncology (CHRS) EBIT (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Coherus Oncology's EBIT was -$158.7 million through Jun 30, 2026; for FY2025, it came in at -$181.13 million.
- In earlier years, EBIT was -$199.65 million in FY2024, -$203.2 million in FY2023, -$256.88 million in FY2022 and -$263.86 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBIT since Q3 2023.
- Per Business Quant data, CHRS's EBIT in the three quarters before Q2 2026 was -$36.15 million (Q1 2026), -$45.88 million (Q4 2025) and -$44.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn | -32.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.33 Mn |
| Mar 31, 2026 | -36.15 Mn |
| Dec 31, 2025 | -45.88 Mn |
| Sep 30, 2025 | -44.33 Mn |
| Jun 30, 2025 | -45.49 Mn |
| Mar 31, 2025 | -45.44 Mn |
| Dec 31, 2024 | -45.38 Mn |
| Sep 30, 2024 | -46.86 Mn |
| Jun 30, 2024 | -39.63 Mn |
| Mar 31, 2024 | -67.79 Mn |
| Dec 31, 2023 | -68.91 Mn |
| Sep 30, 2023 | -32.01 Mn |
| Jun 30, 2023 | -34.54 Mn |
| Mar 31, 2023 | -67.75 Mn |
| Dec 31, 2022 | -51.49 Mn |
| Sep 30, 2022 | -80.45 Mn |
| Jun 30, 2022 | -44.01 Mn |
| Mar 31, 2022 | -80.93 Mn |
| Dec 31, 2021 | -39.55 Mn |
| Sep 30, 2021 | -32.79 Mn |
API Access
Coherus Oncology EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CHRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();